Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke


Phase N/A Results N/A

Eligibility Criteria

Hemiparetic patients (right or left who had thromboembolic non-hemorrhagic infarction (documented by CT or MRI) more than 6 months before. Patients should have recovered motor function to the point of being able to perform thumb movements.
Patients will be recruited from referrals from the community, particularly Baltimore and Washington VA hospitals, and Suburban Hospital as well as stroke clubs. An anatomical MRI scan will be acquired at the NIH if a recent one (within 6 months) is not available.
- Large hemorrhagic or brain stem stroke.
- Multiple cerebral lesions with residual deficits.
- History of head injury with loss of consciousness.
- History of severe alcohol or drug abuse.
- History of psychiatric illness.
- Unstable cardiac dysrhythmia or unresponsive arterial hypertension (greater than 160/100 mmHg).
- H/o hyperthyroidism.
- Receiving alpha-adrenergic antagonists or agonists, major/minor tranquilizers, clonidine,prazosin, phenytoin, benzodiazepines, scopolamine, haloperidol, other neuroleptics, barbiturates.
- Degree of aphasia or cognitive deficit that makes patient unable to give informed consent.
- Pregnancy, glaucoma, h/o hypersensitivity or idiosyncrasy to sympatomimetic drugs.